£100K
A group of eight NorthInvest angels has backed the medical technology developer.
Renephra develops home-based medical technology for chronic fluid overload conditions.
Frontline medical professionals have created a device that enables home treatment for chronic fluid overload and conditions such as lymphoedema.
Cash at bank
Net current assets
Total assets less current liabilities
Net assets
Shareholders' funds
Current assets
Cash, assets and headcount from Renephra's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Idalia Dawidaska
MD
A group of eight NorthInvest angels has backed the medical technology developer.